# Drug Drug Interaction Study for EYP001 With Entecavir

> **NCT03469583** · PHASE1 · COMPLETED · sponsor: **Enyo Pharma** · enrollment: 16 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** EYP001
- **DRUG:** Entecavir 1 MG

## Key facts

- **NCT ID:** NCT03469583
- **Lead sponsor:** Enyo Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-12
- **Primary completion:** 2018-06-20
- **Final completion:** 2018-07-20
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03469583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03469583, "Drug Drug Interaction Study for EYP001 With Entecavir". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03469583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*